Krause v. Kimberly-Clark Corp.
Decision Date | 17 January 1990 |
Docket Number | No. L89-30066 CA1.,L89-30066 CA1. |
Citation | 749 F. Supp. 164 |
Parties | Jill Annette KRAUSE, Plaintiff, v. KIMBERLY-CLARK CORPORATION, Defendant. |
Court | U.S. District Court — Western District of Michigan |
Aryon Greydanus, Lansing, Mich., for plaintiff.
Richard A. Kitch, Kitch, Saurbier, Drutchas, Wagner, et al., Lansing, Mich., Rodney E. VanAusdal, Williams & Montgomery, Ltd., Chicago, Ill., for defendant.
Plaintiff Jill Annette Krause filed the present three-count action in the Ingham County Circuit Court, State of Michigan, against defendant Kimberly-Clark Corporation alleging negligence, failure to provide an adequate warning, and breach of implied warranties. Plaintiff's action arises out of claims that while using defendant's KOTEX Security Super Tampons, she suffered toxic shock syndrome. Defendant removed the action to this Court on the basis of diversity jurisdiction. Presently pending before the Court is defendant's motion for summary judgment pursuant to Federal Rule of Civil Procedure 56. For the reasons stated, defendant's motion is granted in part and denied in part.
Plaintiff Jill Annette Krause alleges that she developed toxic shock syndrome ("TSS") as a result of her use of KOTEX Security Super Tampons ("KOTEX Tampons"). Defendant Kimberly-Clark Corporation is the manufacturer of KOTEX Tampons. Plaintiff alleges that on or about August 7, 1988, she began using KOTEX Tampons. On August 10-11, 1988 plaintiff allegedly suffered from symptoms of TSS. On August 12, 1988, plaintiff was admitted to the hospital and was hospitalized until August 17, 1988. Plaintiff alleges that she continues to suffer from pain allegedly resulting from the TSS caused by her use of KOTEX Tampons.
In May of 1980, the Center for Disease Control first indicated an association between the use of tampons and TSS. See 45 Fed.Reg. 69840 (Oct. 21, 1980); Underhill Affidavit ¶ 3. Thus, in October 1980, Kimberly-Clark mailed letters to physicians and public health agencies warning of the association. Id. at ¶ 4. Kimberly-Clark began placing shelf warnings in retail stores beginning in November 1980. Id. at ¶ 5. In addition, all KOTEX Tampon boxes leaving Kimberly-Clark's possession after October 31, 1980, included a cautionary statement warning of the danger and symptoms of TSS and its possible association with tampon use. Id. at ¶ 6.
On June 22, 1982, the Federal Food and Drug Administration ("FDA") promulgated labeling requirements for all tampon boxes entering the stream of commerce after December 20, 1982. See 21 U.S.C. §§ 360c-360k; 21 C.F.R. § 801.430; 47 Fed.Reg. 26982, 26982-90 (June 22, 1982). Kimberly-Clark complied with the FDA requirements at all times after December 20, 1982, by either displaying an alert statement on the package label and including consumer information in a package insert or by displaying both the alert statement and consumer information on the package label. Underhill Affidavit ¶ 7. Kimberly-Clark's alert statement provides:
ATTENTION: Tampons are associated with Toxic Shock Syndrome (TSS). TSS is a rare but serious disease that may cause death. Read and save the enclosed information.
Kimberly-Clark's consumer information provides:
Defendant has moved for summary judgment arguing that plaintiff's state law tort claims are preempted by federal law and that there is no genuine issue of material fact that it complied with the FDA requirements. Defendant has supported its motion for summary judgment with the affidavit of Robert A. Underhill, defendant's vice president of research. As of the date of this Opinion, plaintiff has not filed a response.1
Summary judgment is appropriate only where no genuine issue of fact remains to be decided so that the moving party is entitled to judgment as a matter of law. Atlas Concrete Pipe, Inc. v. Roger J. Au & Son, 668 F.2d 905, 908 (6th Cir.1982). There is no material issue of fact for trial unless, in viewing the evidence in favor of the non-moving party, a reasonable factfinder could return a verdict for that party. Anderson v. Liberty Lobby, 477 U.S. 242, 249, 106 S.Ct. 2505, 2510, 91 L.Ed.2d 202 (1986). "If the evidence is merely colorable or is not significantly probative, summary judgment may be granted." Id. (citations omitted).
The party moving for summary judgment bears the initial responsibility of informing the court of the basis of its motion and identifying those portions of the record which demonstrate the absence of a material issue of fact. Celotex Corp. v. Catrett, 477 U.S. 317, 323, 106 S.Ct. 2548, 2551, 91 L.Ed.2d 265 (1986). Once this has been done, the non-moving party must come forward with specific facts showing that there is a material issue of fact on an issue which the non-moving party will bear the burden of proof at trial. Fed.R.Civ.P. 56(e); Celotex, 477 U.S. at 322, 106 S.Ct. at 2552. If the non-moving party fails to respond, summary judgment, if appropriate, shall be entered against the non-moving party. Fed. R.Civ.P. 56(e).
The Supremacy Clause of the Constitution requires invalidation of state laws that interfere with or are contrary to federal law. U.S. Const. art. VI, cl. 2. Preemption may be express where Congress explicitly prohibits state regulation. See, e.g., Jones v. Rath Packing Co., 430 U.S. 519, 525, 97 S.Ct. 1305, 1309, 51 L.Ed.2d 604 (1977); Ohio Manufacturers' Association v. City of Akron, 801 F.2d 824, 827-28 (6th Cir.1986), cert. denied, 484 U.S. 801, 108 S.Ct. 44, 98 L.Ed.2d 9 (1987). In the absence of express preemption, preemption can be implied "where the scheme of federal regulation is sufficiently comprehensive to make reasonable the inference that Congress `left no room' for supplementary state regulation." California Federal Savings & Loan Association v. Guerra, 479 U.S. 272, 280-81, 107 S.Ct. 683, 689, 93 L.Ed.2d 613 (1987); Rice v. Santa Fe Elevator Corp., 331 U.S. 218, 230-31, 67 S.Ct. 1146, 1152-53, 91 L.Ed. 1447 (1947). Preemption may also occur where state law conflicts with federal law even if Congress has not completely displaced state regulation. Guerra, 479 U.S. at 281, 107 S.Ct. at 689; Jones, 430 U.S. at 525-26, 97 S.Ct. at 1309-10; Roysdon v. R.J. Reynolds Tobacco Co., 849 F.2d 230, 233-34 (6th Cir.1988).
"State laws can be pre-empted by federal regulations as well as by federal statutes." Hillsborough County, Florida v. Automated Medical Laboratories, Inc., 471 U.S. 707, 713, 105 S.Ct. 2371, 2375, 85 L.Ed.2d 714 (1985); Fidelity Federal Savings & Loan Association v. De la Cuesta, 458 U.S. 141, 153-54, 102 S.Ct. 3014, 3022-23, 73 L.Ed.2d 664 (1982). The ultimate question is congressional intent underlying the regulatory scheme. Hillsborough County, 471 U.S. at 714, 105 S.Ct. at 2375; De la Cuesta, 458 U.S. at 152, 102 S.Ct. at 3022. Further, "where ... the field such as state regulation of health and safety that Congress is said to have pre-empted has been traditionally occupied by the States, `we start with the assumption that the historic police powers of the States were not to be superseded by the Federal Act unless that was the clear and manifest purpose of Congress.'" Hillsborough County, 471 U.S. at 715, 105 S.Ct. at 2376 (quoting Rice, 331 U.S. at 230, 67 S.Ct. at 1152). Finally, "pre-emption is not to be lightly presumed." Guerra, 479 U.S. at 281, 107 S.Ct. at 689.
Federal Regulations classify tampons as Class II medical devices regulated under the Medical Device Amendments of 1976 ("MDA") to the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §§ 301 et seq., 21 C.F.R. §§ 884.5460, 884.5470. See also 21 U.S.C. § 360c (classification of devices); 21 C.F.R. § 860 (classification procedures). As a Class II medical device, tampons are subject to specified performance standards enacted by the Secretary of Health and Human Services "to provide reasonable assurance of their safe and effective performance." 21 U.S.C. § 360d. Devising a performance standard includes "where appropriate, requiring the use and prescribing the form and content of labeling for proper installation, maintenance, operation, and use of the device." 21 U.S.C. § 360d(a)(2)(C).
Section 521(a) of the MDA expressly provides that:
To continue reading
Request your trial-
National Bank of Commerce of El Dorado v. Kimberly-Clark Corp.
...Corp., 867 F.2d 243 (5th Cir.1989); Bejarano v. International-Playtex, Inc., 750 F.Supp. 443 (D.Idaho 1990); Krause v. Kimberly-Clark Corp., 749 F.Supp. 164 (W.D.Mich.1990); Northrip v. International Playtex, Inc., 750 F.Supp. 402 (W.D.Mo.1989); Lindquist v. Tambrands, Inc., 721 F.Supp. 105......
-
Bravman v. Baxter Healthcare Corp.
...duty to warn claims; failure to properly design and construct tampons claims not preempted by federal law); Krause v. Kimberly-Clark Corp., 749 F.Supp. 164, 168-69 (W.D.Mich.1990) (holding state law tort claims of labeling preempted by federal counterpart regulations, but negligence and bre......
-
Ginochio v. Surgikos, Inc.
...the claims relating to warnings are preempted, while other claims are not. See e.g. Moore, 867 F.2d at 247; Krause v. Kimberly-Clark Corp., 749 F.Supp. 164, 169 (W.D.Mich.1990); Bejarano v. International Playtex, Inc., 750 F.Supp. 443, 446 (D.Idaho 1990). Two courts have similarly held that......
-
Reece v. Good Samaritan Hosp.
...Corp., 867 F.2d 243 (5th Cir.1989); Bejarano v. International Playtex, Inc., 750 F.Supp. 443 (D.Idaho 1990); and Krause v. Kimberly-Clark Corp., 749 F.Supp. 164 (W.D.Mich.1990). 4 The Lohr court held that general federal labeling and manufacturing requirements, not specifically applicable t......